Rheumatoid arthritis drugs

Figure 1.6 The structures of (a) the MRI contrast agent Gd-DTPA and (b) the orally active anti-rheumatoid arthritis drug Auranofin .

Culy CR, Keating GM. Etanercept. An updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Drugs 2002 62 2493-537. [Pg.82]

KUnkhoff A. Biological agents for rheumatoid arthritis. Drugs 2004 64 1267-83. [Pg.85]

Langevitz P, Livneh A, Bank I, Pras M. Benefits and risks of minocycline in rheumatoid arthritis. Drug Saf 2000 22(5) 405-14. [Pg.444]

Siddiqui MA, Scott LJ. Infliximab a review of its use in Crohn s disease and rheumatoid arthritis. Drugs 2005 65(15) 2179-208. [Pg.444]

Plosker G, Croom K Sulfasalazine A review of its use in the management of rheumatoid arthritis. Drugs 2006 65 1825. [Pg.822]

Camussi G, Lupia E (1998) The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs 55(5) 613—620... [Pg.296]

Anonymous, Modifying disease in rheumatoid arthritis. Drug Ther. Bull. 36 3-6, 1998. [Pg.313]

Muller-Ladner U, Gay S. The SCID mouse—a novel experimental model for gene therapy in human rheumatoid arthritis. Drugs Today (Barcelona) 1999 35 379-88. [Pg.305]

Mikuls TR, Moreland LW. Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritis. Drug Saf 2003 26(l) 23-32. [Pg.1752]

Cassidy JT. Medical management of children with juvenile rheumatoid arthritis. Drugs 1999 58(5) 831-50. [Pg.2746]

FIGURE 1.9 The orally active anti-rheumatoid arthritis drug Auranofin ... [Pg.14]

Prakash A, Jarvis B. Leflunomide A review of its use in active rheumatoid arthritis. Drugs 1999 58 1137-1164. [Pg.1683]

Chloroquine and other aminoquinolines are used in the prophylaxis or therapy of malaria and other parasitic diseases. Chloroquine and hydroxychloroquine are also used in the treatment of rheumatoid arthritis. Drugs in this class include chloroquine phosphate (Aralen ), amodiaquine hydrochloride (Camoquin ), hydroxychloroquine sulfate (Plaquenil ), mefloquine (Lariam" ), primaquine phosphate, and quinacrine hydrochloride (Atabrine ). Chloroquine overdose is common, especially in countries where malaria is prevalent, and the mortality rate is 10-30%. Quinine toxicity is described on p 326. [Pg.165]

Nichol, F.E. Samanta, A. Rose, C.M. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis. Drugs 1988, 35 (suppl. 1), 46-51. [Pg.288]

Gates BJ, Nguyen TT, Setter SM, devies NM (2005) Meloxicam a reappraisal of pharmacokinetics, efficacy and safety. Expert Opin Pharmacother 6 2117-2140 Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influenee the oral bioavailability of drug candidates. J Med Chem 45 2615-2623 Prakash A, Jarvis B (1999) Leflunomide a review of its use in active rheumatoid arthritis. Drugs 58 1137-1164... [Pg.362]

Ramasamy, Thiruganesh, Hima Bindu Ruttala, Suresh Shaiunugam, Subbiah Kandasamy Umadevi. Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis. Drug Delivery 20, no. 2 (2013), 65-77. [Pg.268]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...